References
- Challenger F, Walshe JM. Foetor hepaticus. Lancet 1955;1: 1239.
- Chen S, Zieve L, Mahadevan V. Mercaptans and dimethylsulfide in the breath of patients with cirrhosis of the liver. J Lab Clin Med 1970;75:628–35.
- Tangerman A, MetiweseArends MT, Jansen JB. Foetor hepaticus. Lancet 1994;1:1569.
- Sherlock S, Dooley J Diseases of the liver and biliary system. 10th ed. Oxford: Blackwell Scientific; 1997. p. 79.
- Finlayson NDC. Hepatic encephalopathy. In: Shearman WC, Finlayson N, Camilleri M, Carter D, editors. Diseases of the gastrointestinal tract and liver. 3rd ed. New York: Churchill Livingstone; 1997. p. 1046.
- Muting D, Reikowski J, Fischer R, Kalk JR. Ursachen, Diagnostikkriterien des Coma hepaticum—Eine Analyse von 560 Fallen. Leber Magen Darm 1983;13:85–93.
- De La Huerga J, Popper M. Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary disease. J Clin Invest 1951;30:463 70.
- Hayes RJ, Mitchell SC, Smith RL. Cholinergic action of trimethylamine and its metabolites. Br J Pharmacol 1986;95: 916.
- Marks R, Dudley F, Wan A. Trimethylamine metabolism in liver diseases. Lancet 1978;1:1106–7.
- Dolphin CT, Janmohamed A, Smith RL, Shephard EA, Phillips IA. Missense mutation in flavincontaining monooxygenase 3 gene, FMO3, underlies fishodour syndrome. Nat Genet 1997; 17:491–4.
- Mitchell SC. The fishodor syndrome. Perspect Biol Med 1996;39:514–26.
- Zhang AQ, Mitchell SC, Ayesh R, Smith RL. Determination of trimethylamine and related aliphatic amines in human urine by headspace gas chromatography. J Chromatogr 1992;584:141–5.
- Zhang AQ, Mitchell SC, Smith RL. Discontinuous distribution of N-oxidation of dietaryderived trimethylamine in a British population. Xenobiotica 1996;26:957–61.
- AlWaiz M, Ayesh R, Mitchell SC, Idle JR, Smith RL. Trimethylaminuria (‘fishodour syndrome’): a study of an affected family. Clin Sci 1988;74:231–6.
- Brewster MA, Schedewie H. Trimethylaminuria. Ann Clin Lab Sci 1983;13:20–4.
- Dorland L, deVries T, vanVossen R, Duran M, Wadman SK, Mienie U. Trimethylaminuria, diagnosed by gas chromatography with nitrogen detection. J Inherit Metab Dis 1987;10:401–2.
- King GS, Pettit BR, Leonard JV. The analysis of trimethylamine in body fluids by a direct medium resolution mass spectrometric method. Biomed Mass Spectrom 1984;11:1–3.
- Marks R, Greaves MW, Prottey C, Hartop PJ. Trimethylaminuria: the use of choline as an aid to diagnosis. Br J Dermatol 1977;96:399–402.
- Treacy E, Johnson D, Pitt JJ, Danks DM. Trimethylaminuria, fish odour syndrome: a new method of detection and response to treatment with metronidazole. J Inherit Metab Dis 1995;18:306–12.
- Ayesh R, Mitchell SC, Zhang A, Smith RL. The fish odour syndrome: biochemical, familial and clinical aspect. Br Med J 1993;307:655–7.
- Mitchell SC, Zhang AQ, Smith RL. Fishodour syndrome and impaired Noxidation. Biochem Soc Trans 1996;24:96S.
- Wranne L. Urinary excretion of trimethylamine and trimethyl amine oxide following trimethylamine administration to normals and patients with liver disease. Acta Med Scand 1956;153:433–41.
- Wilkinson GR, Schenker S. Drug disposition in liver disease. Drug Metab Rev 1975;4:139–75.
- Dolphin CT Effects of immune system modulation upon in vivo drug metabolism [thesis]. London: University of London; 1988. p. 106–17.
- Ruocco V, Florio M, Grimaldi Filioli F, Guerrer AV, Prota G. An unusual case of trimetylaminuria. Br J Dermatol 1989;120: 459–61.